Last $8.15 USD
Change Today -0.345 / -4.06%
Volume 618.8K
MDXG On Other Exchanges
As of 4:30 PM 01/30/15 All times are local (Market data is delayed by at least 15 minutes).

mimedx group inc (MDXG) Snapshot

Previous Close
Day High
Day Low
52 Week High
12/22/14 - $11.97
52 Week Low
05/7/14 - $4.88
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for MIMEDX GROUP INC (MDXG)

Related News

No related news articles were found.

mimedx group inc (MDXG) Related Businessweek News

No Related Businessweek News Found

mimedx group inc (MDXG) Details

MiMedx Group, Inc., together with its subsidiaries, designs, manufactures, and markets products and tissue processing services in the United States. The company’s products include patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane. Its biomaterial platform technologies comprise AmnioFix and EpiFix, which are tissue technologies processed from human amniotic membrane that is derived from donated placentas. Through the company’s donor program, mothers delivering full-term Caesarean section births can elect in advance of delivery to donate the placenta in lieu of having it discarded as medical waste. It processes the human amniotic membrane utilizing its proprietary PURION process to produce a safe and effective implant. The company also provides CollaFix, a medical device technology platform. It supplies amniotic tissue on OEM basis for application in the wound care, surgical, sports medicine, ophthalmic, and dental sectors of healthcare through direct sales force, independent sales representatives, and distributors, as well as through private label or OEM relationships. The company is headquartered in Marietta, Georgia.

222 Employees
Last Reported Date: 03/4/14

mimedx group inc (MDXG) Top Compensated Officers

Chairman and Chief Executive Officer
Total Annual Compensation: $465.2K
President, Chief Operating Officer and Direct...
Total Annual Compensation: $385.6K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $268.3K
Vice President, General Counsel and Consultan...
Total Annual Compensation: $240.0K
Compensation as of Fiscal Year 2013.

mimedx group inc (MDXG) Key Developments

MiMedx Group, Inc. Reaffirms Earnings Guidance for 2015; Announces Revenue Results for the Fourth Quarter and Full Year Ended December 31, 2014

On December 15, 2014, the company issued a press release announcing its expectations for 2015. Included in that guidance were revised expectations for full year 2015 revenue to be in the range of $175.0 million to $190.0 million, up from earlier expectations of $175.0 million to $185.0 million. The company reiterated this upgraded 2015 guidance in its press release of January 6, 2015. MiMedx Group, Inc. announced revenue results for the fourth quarter and full year ended December 31, 2014. The company recorded record revenue for the year ended December 31, 2014 of $118.2 million, a $59.0 million or 100% increase over 2013 revenue of $59.2 million. The company recorded record revenue for the 2014 fourth quarter of $39.6 million, a $21.6 million or 120% increase over 2013 fourth quarter revenue of $18.0 million.

MiMedx Group, Inc. - Shareholder/Analyst Call

To present prepared remarks and respond to questions regarding its lawsuit against Organogenesis

MiMedx Group Provides Revenue Guidance for the Fourth Quarter and Full Year 2014

MiMedx Group expects to exceed the upper end of its revenue guidance for both fourth quarter and full year 2014. For the fourth quarter of 2014, the company expects revenue to be in the range of $37.3 million to $38.3 million. For the full year, the company expects revenue to be in the range of $116 million to $117 million.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MDXG:US $8.15 USD -0.345

MDXG Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Shire PLC 4,854 GBp -44.00
View Industry Companies

Industry Analysis


Industry Average

Valuation MDXG Industry Range
Price/Earnings 100.0x
Price/Sales 9.3x
Price/Book 11.2x
Price/Cash Flow 473.4x
TEV/Sales 8.9x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MIMEDX GROUP INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at